Joshua Love is a co-founder of Zite AI, where they build AI software for healthcare administration, including forecasting patient volumes to help health systems plan care sites, budgets, and staffing.
Joshua Love is most useful for founder-led thought leadership on AI for healthcare site-of-care planning.
Best for
A healthcare technology company selling forecasting or analytics to health systems.
Not for
A consumer brand or general-interest publisher seeking large general-audience video reach.
Key takeaways
Health systems open new care sites without projecting patient volume and pay for it.
One health system paid $2 million for a site-of-care plan and $1 million to validate it.
The business followed a buyer's problem, not the founders' original plan.
Check first: Confirm audience reach, engagement, and audience match before committing budget.
Main ideas
Industry-specific AI, not general AI, will force organizations to change · Health systems open new care sites without projecting patient volume — and pay for it · The business followed a buyer's problem, not the founders' original plan
Joshua Love is a co-founder of Zite AI, a company building AI software for healthcare administration.
In the posts reviewed, they explain the company’s shift from retail site-selection ideas to helping health systems plan patient volumes and care locations.
Their writing connects that work to practical decisions about opening clinics, setting budgets, and staffing.
Follow them for founder accounts of that pivot and arguments about where industry-specific AI may be useful.
Love makes a complex planning problem concrete with vivid contrasts: one health system paid $2 million for a site-of-care plan and $1 million to validate it, while two seemingly similar urgent-care sites drew 15,000 visits a year and 5,000.
Those examples show why patient-volume forecasts matter, rather than merely asserting that AI can improve healthcare.
They also write for broader audiences about domain-specific AI, using legal tools and emergency-room cameras as illustrations of possible AI uses, not as described Zite AI products.
Joshua Love writes about why AI built for a single industry matters, and the healthcare planning problem Zite AI was built to solve.
Read more
Three posts share the same shape: a counterintuitive claim about how an industry works, a specific figure or scenario as support, and a closing challenge or cost statement. The priorities are validated demand over an original idea, concrete numbers over general claims, and healthcare work that affects patients rather than retail convenience.
Industry-specific AI, not general AI, will force organizations to change
Love argues that the AI worth watching is built for one field at a time — weather forecasting, fraud detection, supply chains — rather than as a general-purpose model.
Read more
Healthcare administration is Zite AI's version.
The case for it: AI does not forget, tire, or make decisions based on office politics or gut feelings, so within three to five years, AI-driven tools will outperform seasoned experts on key tasks.
Love urges readers to act: research AI startups in your field now, because early adopters will be harder to outmaneuver.
The post lists three uses to make the shift concrete: sales CRMs that listen to calls and generate timed outreach, emergency-room security cameras that flag high-risk patients on arrival, and legal tools that pull relevant case law while a lawyer interviews a client. These examples reach across sales, hospital security and law, beyond the healthcare-administration category Love's own company works in.
Health systems open new care sites without projecting patient volume — and pay for it
Love's sharpest operational argument: systems rarely build pro-forma projections for patient volume at new sites, even though each is a multi-million-dollar investment.
Read more
Because projections have rarely matched reality, systems fall back on rough rules of thumb or guesswork.
Some set a viability threshold, such as 10,000 patients a year for a primary care site; others open a location assuming it will succeed, then close it about three years later.
Love puts the failure rate at one in five new sites within the first five years, and says each closure diverts money from patient outcomes.
Two urgent care sites that look identical, in markets that look identical, drew 15,000 visits a year in one case and 5,000 in the other. Love uses the gap to explain why health systems stopped trusting their own projections.
The business followed a buyer's problem, not the founders' original plan
Love traces Zite AI through two ideas the founders abandoned before healthcare.
Read more
The first was to use AI to predict commercial real estate development, buy land there and resell it; the idea stalled because Love and co-founder Jacob were graduate students without $100M.
The second forecast how many customers a store should expect so retailers could choose a location.
It reached the finals of the Cozad New Venture Challenge but did not crack the market after more than 100 customer discovery interviews.
The turn came when a health system CEO described the same forecasting question in a harder form: systems need patient volumes to decide where to open clinics, set budgets and allocate staff.
Unlike retail, not every patient generates revenue; a patient journey can involve emergency visits, referrals, research and word of mouth.
Love says the priority is the outcome: building something that helps people get healthy instead of helping sell more hamburgers.
The CEO told them their system had paid $2M to a consulting firm for a site-of-care plan and another $1M to a second firm to validate it, then reacted to the Zite AI demo: "you mean AI can do this in seconds?
Explains where Zite AI came from and why it landed on healthcare rather than retail—the clearest account of what Love is building and for whom.
Read more
Love describes the company's pivot in stages.
The original plan was to use AI to predict where commercial real estate development would happen, buy land there, and later flip it.
That stalled because, as they put it, they and co-founder Jacob were graduate students with no $100M.
The next concept projected how many customers a store should expect so retailers could choose locations.
It reached the finals of the Cozad New Venture Challenge, but 100-plus customer discovery interviews still did not crack the market.
The turn came when a health system CEO explained that healthcare faces the same question in a harder form: systems must anticipate patient volumes to decide where to open clinics, set budgets, and allocate staff.
Unlike retail, not every patient generates revenue, because the patient journey runs through emergency visits, referrals, research, and word of mouth.
Love recounts the CEO paying $2M to a consulting firm for a site-of-care plan and another $1M to a second firm to validate the first, then reacting to a demo with "you mean AI can do this in seconds?"
They close by saying they would rather build something that helps people get healthy than help sell more hamburgers.
For brands planning a campaign
This is the strongest founder-story asset: it shows a documented pivot validated by a paying healthcare buyer, not a market the founders chose on their own. It suits a narrative-led collaboration aimed at health system executives, with the $3M in stacked consulting spend making the problem tangible.
Answers the question healthcare readers ask after the origin story: if this problem is real, how bad is it?
Read more
It is the sharpest and most quotable statement of scale in the material.
Love argues that health systems do not build pro-forma patient-volume projections for new sites of care, despite the size of the investments.
Instead, they either set a viability threshold, such as needing 10,000 patients a year to make primary care work, or guess and check—opening a site, assuming it will succeed, and closing it three years later.
The consequence they cite is that one in five new sites fails within the first five years.
Their core argument is that past attempts rarely matched reality: two seemingly identical urgent cares in seemingly identical markets drew 15,000 visits a year in one case and 5,000 in the other.
They frame each failed site as millions of dollars that could have gone to improving outcomes for communities.
For brands planning a campaign
Use this as the problem-statistics spine of a campaign.
The one-in-five failure rate and the 15,000-versus-5,000 variance are concrete and memorable, and tie directly to budget consequences.
They can anchor a short-form piece or a lead magnet aimed at planning and strategy roles.
Explains Love's view of AI beyond healthcare administration: the general thesis behind the company's positioning and a glimpse of how they write for a non-specialist audience.
Read more
Love argues that domain-specific AI is already reshaping industries—citing weather prediction, fraud detection, and supply chain optimization—while attracting far less attention than general-purpose AI.
They position Zite AI as an example in healthcare administration.
They predict a three-to-five-year window in which organizations either adopt AI-driven tools or fall behind, and list illustrative uses: sales software that listens to calls and generates timed outreach, security cameras that flag high-risk patients on arrival at an emergency room, and legal tools that pull case law while a lawyer interviews a client.
AI, they argue, wins because it does not forget, tire, or decide based on office politics or gut feelings.
They close by telling readers to research AI startups in their own field.
For brands planning a campaign
This cross-industry piece is useful when a collaboration needs to reach beyond healthcare operations or take a conversational rather than technical approach. The security-camera and legal examples are speculative illustrations of AI generally, not described Zite AI products; ask which capabilities, if any, are shipped before presenting them as products.
A consistent approach: numbers, buyer economics and first-person founder framing3
Domain-specific AI and the pressure to adopt it1
Site-of-care planning is guesswork, and it is expensive1
Why Zite AI moved into healthcare: a pivot told through discovery1
Domain-specific AI and the pressure to adopt it
Joshua Love argues that AI built for one industry rather than general use is already reshaping fields such as weather forecasting, fraud detection and supply chains, and that healthcare administration is next.
Read more
The post claims AI can process more information than people, does not forget or tire, and will outperform experienced staff on key tasks within three to five years.
It gives three concrete illustrations of that shift: sales CRMs that listen to calls and time outreach, security cameras that flag high-risk patients arriving at an emergency room, and legal tools that pull case law while a lawyer interviews a client.
The closing instruction is to research AI startups in one's own field before competitors do.
A forward-looking prediction, backed by a short bulleted list of examples, followed by a direct challenge to the reader.
The three examples span sales, hospital security and law rather than healthcare administration alone, so the post reaches beyond Love's own product category.
For brands planning a campaign
A brand selling vertical AI can use this framing directly: the argument is not that AI is generally useful, but that industry-specific AI creates a deadline. It suits campaigns that pair a category claim with named, tangible use cases rather than abstract capability language.
Site-of-care planning is guesswork, and it is expensive
Love's sharpest operational argument is that health systems do not build pro-forma patient projections before opening new sites of care.
Read more
Some set a rough threshold, such as 10,000 patients a year for a primary care site to be viable; others open a location, assume it will work and close it roughly three years later.
They report that one in five sites fails within five years, projections rarely match reality, and two apparently identical urgent care sites in apparently identical markets can draw 15,000 and 5,000 visits a year.
The stakes are multi-million-dollar investments and money that could have gone to patient outcomes.
Problem-first structure: state the counterintuitive practice, supply a failure rate and a variance example, then close on the cost to patients.
For brands planning a campaign
This is the most useful item for a healthcare technology brand. It names a specific, costly buyer problem with numbers attached, making it a natural anchor for a content collaboration on forecasting, site selection or capital allocation rather than a general AI theme.
Why Zite AI moved into healthcare: a pivot told through discovery
Love describes Zite AI's original plan: predict commercial real estate development, buy land and resell it.
Read more
The founders abandoned it because they were graduate students without capital.
Their next concept forecast customer traffic so retailers could pick store locations.
It reached the finals of the Cozad New Venture Challenge but did not crack the market after more than 100 customer discovery interviews.
The pivot to healthcare came through a conversation with a health system CEO, who described paying $2M to a consulting firm for a site-of-care plan and another $1M to a second firm to validate it, then reacting with surprise when Zite AI's technology worked in seconds.
First-person narrative in chronological order, anchored to specific figures: $100M, 100+ interviews, $2M and $1M in consulting fees.
For brands planning a campaign
For a brand that wants founder-story content, this supplies a complete narrative arc: an idea that failed for a concrete reason, validated discovery work and a customer conversation that redirected the business. It works for campaigns about building in healthcare, customer-discovery discipline or why domain knowledge beats a general model.
A consistent approach: numbers, buyer economics and first-person founder framing
Across the posts, Love builds arguments the same way: open with a claim that sounds counterintuitive, support it with named figures or concrete scenarios, and close with either a challenge to the reader or a cost statement.
Read more
The subject matter narrows from broad AI adoption to the operational and economic detail of healthcare site planning. Two posts use founder biography, and all three keep the language plain and reader-directed rather than technical.
The posts vary in structure, evidence type and voice.
For brands planning a campaign
A brand can plan content around this pattern rather than a single topic. Love is likely to produce usable content on subjects with specific cost or volume figures, and less useful content on abstract themes without numbers to anchor them.
The posts document one brand relationship: Zite AI, the healthcare-administration AI company Love describes as a company they founded.
Read more
No sponsorships, affiliate relationships, client work, investments, or disclosed partnerships appear in the posts here.
Zite AI
Owned business
Love writes as “an AI founder” and describes Zite AI as the company they and Jacob began building after earlier concepts.
Read more
The posts say Zite AI makes domain-specific AI for healthcare administration, including forecasting patient volumes so health systems can plan sites of care, budgets, and staffing.
One is the case for AI built for a single industry, with healthcare administration as the field they know best.
The other is the operational detail of that case, especially how health systems decide where to open sites of care and how often those decisions go wrong.
A third thread is the origin story of Zite AI, told through the ideas that failed before the healthcare one worked.
Start with the post on site-of-care planning, the most specific and useful for a healthcare audience.
Then read the case for domain-specific AI and the founder narrative, which explains how the other two connect.
Belkin writes for the same audience as Love — people running healthcare delivery organizations — and uses the same basic move: identify a reactive, expensive practice, support the case with specific figures and argue for planning ahead.
Read more
In a post on physician staffing, Belkin says coverage gaps are addressed only once they become urgent and that proactive workforce planning means forecasting demand by service line before gaps emerge.
A post on burnout supplies specialty-level numbers and treats burnout as a leading indicator of turnover rather than as stress.
That structure and audience closely match Love's argument that health systems should forecast patient volumes before committing to a site.
Belkin focuses on the clinician workforce — recruitment, retention, locums and other flexible staffing models — drawing on 22 years of client experience.
Love focuses on patient-demand forecasting and the AI product built around it; their posts describe a founder's account of a customer conversation and market failure rates.
Follow Belkin for staffing and retention thinking; follow Love for site selection, volume forecasting and vertical AI.
Brenda S. writes to healthcare and workplace leaders about change that has to be anticipated rather than absorbed.
Read more
Their first-person, concrete style resembles Love's: a new director role, a specific dinner with named colleagues, and the argument that transformation happens where people, strategy, operations and storytelling meet. Both write plainly, avoid technical vocabulary and argue that the people side of an operational decision determines whether it works.
Brenda S. writes about leadership and workforce experience, not operations or forecasting.
Their posts offer personal reflection and community-building — a career change and a small-group gathering they run — rather than figures on demand, cost or failure rates.
Follow Brenda S. for leadership development and team culture; follow Love for the numbers behind a health system's capital and planning decisions.
Johnson works on the operations side of the same healthcare questions Love raises.
Read more
His post on moving from point solutions to a platform argues that decisions about access, capacity, patient flow and staffing should reinforce one another instead of sitting in silos — the same complaint Love makes about planning done guess by guess.
His Labor Day post walks through a patient journey — bed preparation, transport, case management — and credits the roles a patient never sees.
That concrete, plain-language approach matches Love's use of specific examples rather than abstractions.
Johnson writes as an operator rather than a founder: there is no product, no pitch and almost no numbers.
His strongest material is narrative about how care actually moves through a system.
Love's posts make arguments about forecasting, backed by figures and a company.
Follow Johnson for patient flow, operational intelligence and how hospital departments fit together; follow Love for why the forecasting those operations depend on is hard to get right.
This is a small, topic-focused LinkedIn presence built around AI for healthcare administration and patient-volume forecasting.
Read more
The three posts target health system decision makers and operators: the 29 August 2025 post says health systems rarely build pro-forma projections for new sites of care and closes on the cost to patients; the 19 September 2025 post explains the pivot from commercial real estate to healthcare.
Other examples include the 31 January 2025 post on domain-specific AI and the 19 September 2025 origin story.
Joshua Love’s posts don’t identify who is reading.
The follower count on 11 October 2026 (2,103) indicates account size, but the posts provide no age, geography, job function or seniority data, and no engagement figures to compare reach or interaction across topics or formats.
For a health technology company scouting thought leadership on AI-driven site-of-care planning, the subject match is plausible, but the audience match is unverified.
Before committing to a content collaboration, ask for recent results on comparable posts, including impressions and engagement rates; any audience survey covering geography, age, gender, and job role or seniority; and a short sample of recent posts showing the professional audience the writing is intended to reach.
The posts here contain no documented sponsorship, brand-partnership, or commercial collaboration offer from Joshua Love.
Read more
All three posts are written in the voice of a Zite AI co-founder explaining the company's work and the healthcare site-of-care problem; none of them mentions sponsored content, paid placements, affiliate arrangements, or a media kit.
Two posts do reference a company, Zite AI, and a co-founder named Jacob, so a brand approach would most plausibly be a business or product-level conversation with Zite AI rather than an individual creator sponsorship.
This is a statement about what the posts here do and do not document, not a claim that Love never accepts sponsorships or partnerships.
For a buyer planning a content collaboration, the practical requirement is to open that conversation directly rather than select from a published format menu, and to expect the collaboration to run through the company rather than a personal channel.
Good fit on subject and argument, conditional on audience validation. Confirm reach and engagement before committing budget.
Read more
Brief
A healthcare technology company selling forecasting or analytics to health systems wants Love as a thought-leadership voice on AI-driven site-of-care planning and proposes a content collaboration.
Reasons
The topic is central to Love’s writing, not an adjacent theme. In a 29 August 2025 post, they frame the problem in a buyer’s terms: health systems don’t build pro-forma patient-volume projections for new sites of care; some set a threshold, such as 10,000 patients a year for primary care, while others open and close sites; and one in five new sites fails within five years. A campaign on this subject can draw on an argument Love has already made in public.
The numbers are ready to use. Two apparently identical urgent cares in apparently identical markets draw 15,000 visits a year in one case and 5,000 in the other—a ready-made hook for a short-form piece, webinar, or lead magnet aimed at strategy and planning roles.
Love has a documented, buyer-validated origin story. In a 19 September 2025 post, they describe a health system CEO who paid $2M to one consulting firm for a site-of-care plan and $1M to a second to validate it, then asked why AI couldn’t do it in seconds. It’s a usable narrative for the healthcare technology company’s target audience.
Love’s writing suits a campaign aimed at CFOs. Across all three posts, they open with a counterintuitive claim, support it with named figures or concrete scenarios, and close with a challenge or cost statement. That structure transfers cleanly to sponsored thought leadership, and the plain, reader-directed voice needs little adaptation.
Conditions
Audience match is unverified. Joshua Love’s posts target health system decision makers, but don’t establish who actually reads them. They publish no impressions, engagement rates, or audience survey data.
The audience is small: Love had 2,103 LinkedIn followers on 11 October 2026. No comparable engagement figures are available for these posts.
The posts document no commercial format: they don’t mention sponsored content, paid placements, a rate card, or a media kit. Love writes as a Zite AI co-founder, explaining the company’s work. Plan for a business-level conversation with Zite AI rather than a published creator menu.
What to ask before committing
Before committing, request recent performance for comparable posts—impressions and engagement rates in the same subject area—along with any audience survey covering geography, age, and job role or seniority. Ask for a short sample of recent posts showing the professional audience the writing is intended to reach.
When to choose a specialist
Poor fit. Decline or redirect.
Read more
Brief
A consumer brand or general-interest publisher wants sponsored short-form video distributed to a large general audience, with reach measured in views and follower count.
Reasons
There is no video or audio among the three text-only LinkedIn posts, so they don’t demonstrate that Love can carry a short-form video format. A video title would not serve as a transcript, and none is published.
The documented audience is narrow and professional: Love’s material targets health system operators and decision makers. They had 2,103 LinkedIn followers on 11 October 2026, and no engagement data is available. The evidence doesn’t show a channel with the broad reach a consumer campaign needs.
No sponsorship offer is documented in the posts here. None of the three posts mentions sponsored content, paid placements, affiliate arrangements, a rate card, or a partnership contact. That is a statement about what the posts do and do not document, not a claim that Love never accepts sponsorships.
The subject matter doesn’t match: the posts address healthcare administration, patient-volume forecasting, and the origins of Zite AI. One closes with Love’s stated preference for building something that helps people get healthy over helping sell more hamburgers. A generic consumer pitch would not travel well on the existing material.
Any collaboration would most plausibly run through Zite AI: two posts name the company and co-founder Jacob, and all three use the co-founder voice. The posts provide no basis for a personal-creator sponsorship structure.
A worked campaign example
Brief
The healthcare technology company wants to assess Joshua Love for thought leadership on AI-driven site-of-care planning and propose a content collaboration.
Campaign angle
Make the one-in-five failure rate the campaign’s spine, and use Love’s consulting-spend story to show what the problem costs. The angle isn’t “AI is coming” in the abstract. It’s that health systems already pay to answer the patient-volume question twice—and still get it wrong.
Decision summary
Use Love for the argument and narrative on AI-driven site-of-care planning. Answer the audience question first, and route delivery through Zite AI. Don’t build the campaign around video, consumer reach, or a published sponsorship format.
Formats worth proposing
A co-authored long-form LinkedIn post built around the failure-rate and variance numbers.
A short explainer or lead magnet for planning and strategy roles, using the 15,000-versus-5,000 comparison as the opening example, without a graphic in the first draft.
A recorded or written Q&A about the pivot from retail forecasting to healthcare, aimed at health system executives rather than founders.
A joint webinar or roundtable where Love presents the problem and the healthcare technology company presents the forecasting method. Keep the product demonstration on the client’s side: Love’s posts make an argument, not demonstrate a product.
Guardrails
Don’t present the security-camera and legal examples as shipped Zite AI capabilities; they’re speculative illustrations of AI generally.
Do not present Love as a paid creator with an available sponsorship package; no such offer is documented. Route the conversation through Zite AI.
Ask for audience composition, reach, and engagement figures before budgeting the collaboration.
Treat Zite AI’s product claims as unverified: the failure rate, consulting fees, and market outcomes come from Love’s own account in the posts here.
If the client needs verified access to health system executives rather than a writer who addresses them, ask for evidence that the audiences overlap.
Worked sequence
Open with the 15,000-versus-5,000 comparison from the 29 August 2025 post: two urgent cares in seemingly identical markets, with a threefold gap in visits. This is the anchor readers will repeat.
Follow with the one-in-five failure rate and the cost framing: each failed site represents millions of dollars that could have gone to patient outcomes.
Add the buyer-validation story from the 19 September 2025 post: $2M for a site-of-care plan, $1M to validate it, and the CEO’s question about why AI could not do it in seconds.
Close with the three-to-five-year adoption argument from the 31 January 2025 post. Keep the healthcare examples up front, and present the sales, security, and legal illustrations as general examples of AI, not Zite AI products.
Choose Belkin over Joshua Love when the campaign should lead with clinician supply and workforce planning rather than site-of-care demand.
Read more
Belkin's 11 April 2026 post argues that healthcare delivery organizations cannot treat physician staffing as a reactive function: patient access and revenue stability depend on anticipating clinician supply.
That means forecasting demand by service line, tracking retirement and attrition, and building pipelines before gaps appear.
A technology company whose product forecasts coverage gaps, staffing needs, or service-line demand is making Belkin's case, which they have already made publicly from an operator's position after 22 years of client work rather than a vendor founder's.
Belkin's posts focus on clinician supply and staffing pipelines, not patient-volume projections for new sites of care.
The 11 April 2026 post covers workforce planning, so the one-in-five site failure rate and the 15,000-versus-5,000 urgent-care comparison anchoring Love's argument have no equivalent in Belkin's writing.
The 28 April 2026 post reports specialty-level burnout figures and argues for locums, PRN, rapid-response, and fractional models, speaking to staffing and recruiting audiences rather than strategy and planning roles.
Neither post makes an AI argument or shows a buyer's decision being made or changed.
Ask for a product-focused example if the campaign centres on forecasting volumes with AI; Belkin brings workforce credibility, but not that product narrative.
Choose Brenda S. when the collaboration is a hosted conversation with health system leaders rather than a written argument about forecasting.
Read more
The 17 March 2026 post describes a dinner of six leaders run with no titles and no presentations, reports what people said about being stretched and what they were building, and invites readers to direct-message for one of ten seats at a San Diego gathering.
The 11 August 2026 post announces a director role at Kaiser Permanente Care at Home across Southern California and Hawaii and traces a career through workforce wellbeing programmes, cross-functional implementations, sales and benefits, a consulting practice, and authorship.
For a healthcare technology company seeking an executive roundtable, a dinner series, or a people-and-experience angle to open doors with health system operators, Brenda S. brings a documented convening practice and a first-person account of running operational work inside a health system.
For a campaign about site-of-care planning, Brenda S. is the weaker choice.
The two posts—a job announcement and a leadership gathering—do not discuss patient-volume projections, site-of-care planning, forecasting methods, analytics, or AI.
The failure-rate and variance numbers the campaign needs would have to come from another voice.
The gathering post asks readers to contact Brenda S. directly for seats, making a hosted event a likelier collaboration than a written thought-leadership piece.
A client that needs the argument itself rather than the room should look elsewhere.
Choose Chris Johnson when the campaign's message is the platform argument rather than the prediction argument.
Read more
The 22 September 2026 post says health systems assembled technology one point solution at a time and now ask how those capabilities work together.
It argues that the next phase of digital transformation will be won by connecting operational intelligence across access, capacity, patient flow, staffing, and care delivery rather than accumulating more technology.
That is the purchase case a platform vendor is making, and Johnson has already published it.
The 3 September 2026 post grounds the same theme in a personal account of a family member's fall, walking through the case managers, doctors, nurses, environmental services teams, transporters, and administrators whose separate roles a patient experiences as one journey.
A technology company selling an enterprise platform rather than a single application will find Johnson's published position closer to its own pitch than Love's.
Johnson supplies the why-connect-it half of the campaign, not the how-to-predict half.
Neither post contains forecasting numbers, failure rates, market examples, or a method for projecting patient volumes; the one-in-five site failure rate and the 15,000-versus-5,000 comparison have no counterpart.
The 22 September 2026 post names technology and operational intelligence in general terms but does not single out AI.
The 3 September 2026 post reflects on patient flow rather than planning or analytics.
A campaign whose hook is AI producing patient-volume projections in seconds would need to pair Johnson with the quantitative case from elsewhere.
Joshua Love's LinkedIn posts include a case for industry-specific AI (31 January 2025), an argument about how health systems choose new sites of care (29 August 2025), and an account of Zite AI's move into healthcare (19 September 2025).
No video, audio, transcripts, longer articles or third-party coverage appear here.
The posts here provide no engagement or audience-composition data.
A LinkedIn follower count of 2,103 on 11 October 2026 is the only audience-size figure stated here.
The company description, the one-in-five site failure rate and the consulting fees are claims in Love's own posts rather than independent reporting.
Love's posts do not say there is a sponsorship offer, media kit or paid creator format, so this page does not present one.